As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
Researchers at the University of Michigan are developing a pill that makes tumors light up when exposed to infrared light, and they have demonstrated that the concept works in mice.
Mammography is an imprecise tool. About a third of breast cancer patients treated with surgery or chemotherapy have tumors that are benign or so slow-growing that they would never have become life-threatening, according to a study out of Denmark last year. In other women, dense breast tissue hides the presence of lumps and results in deaths from treatable cancers. All that, and mammograms are notoriously uncomfortable.
“We overspend $4 billion per year on the diagnosis and treatment of cancers that women would never die from,” said Greg Thurber, U-M assistant professor of chemical engineering and biomedical engineering, who led the team. “If we go to molecular imaging, we can see which tumors need to be treated.”
The move could also catch cancers that would have gone undetected. Thurber’s team uses a dye that responds to infrared light to tag a molecule commonly found on tumor cells, in the blood vessels that feed tumors and in inflamed tissue. By providing specific information on the types of molecules on the surface of the tumor cells, physicians can better distinguish a malignant cancer from a benign tumor.
Compared to visible light, infrared light penetrates the body easily—it can get to all depths of the breast without an X-ray’s tiny risk of disrupting DNA and seeding a new tumor. Using a dye delivered orally rather than directly into a vein also improves the safety of screening, as a few patients in 10,000 can have severe reactions to intravenous dyes. These small risks turn out to be significant when tens of millions of women are screened every year in the U.S. alone.
But it’s not easy to design a pill that can carry the dye to the tumor.
“To get a molecule absorbed into the bloodstream, it needs to be small and greasy. But an imaging agent needs to be larger and water-soluble. So you need exact opposite properties,” Thurber said.
Fortunately, they weren’t the only people looking for a molecule that could get from the digestive system to a tumor. The pharmaceutical company Merck was working on a new treatment for cancer and related diseases. They got as far as phase II clinical trials demonstrating its safety, but unfortunately, it wasn’t effective.
“It’s actually based on a failed drug,” Thurber said. “It binds to the target, but it doesn’t do anything, which makes it perfect for imaging.”
The targeting molecule has already been shown to make it through the stomach unscathed, and the liver also gives it a pass, so it can travel through the bloodstream. The team attached a molecule that fluoresces when it is struck with infrared light to this drug. Then, they gave the drug to mice that had breast cancer, and they saw the tumors light up.
The research is described in a study in the journal Molecular Pharmaceutics, titled, “Oral administration and detection of a near-infrared molecular imaging agent in an orthotopic mouse model for breast cancer screening.”
The Latest on: Breast cancer diagnosis
via Google News
The Latest on: Breast cancer diagnosis
- Don’t ignore these breast cancer signs & symptoms—if you have 1 or more, do see your doctor on December 13, 2018 at 5:15 pm
If you’re a woman, there’s a roughly one-in-eight chance that you’ll end up with breast cancer during your lifetime. Therefore, it’s more than worth it to know exactly how to detect your risk—no matte... […]
- Julia Louis-Dreyfus Was 'To-My-Bones Terrified' After Her Breast Cancer Diagnosis on December 12, 2018 at 1:58 pm
Julia Louis-Dreyfus has been candid about her breast cancer journey, from her diagnosis in September 2017 to the chemotherapy treatment that finished in January and a subsequent surgery. Now, in a new ... […]
- Wife of UL Lafayette's Athletic Director speaks out about recent breast cancer diagnosis on December 12, 2018 at 6:15 am
LAFAYETTE, La. (KLFY) - Fighting to find a cure, the Autonation Cure Bowl raises funds for the Breast Cancer Research Foundation. The AutoNation Cure Bowl is more than just a game for UL Lafayette's A... […]
- 'I Was Diagnosed With Breast Cancer While Pregnant – And Went Into Chemo At Christmas' on December 11, 2018 at 9:00 pm
Pregnancy is one of the happiest times of many women’s lives – a time of excitement, mixed with understandable trepidation. But for some, everyday worries about birth, parenting and sleepless nights a... […]
- Can using radiomics during screening mammography improve breast cancer diagnosis? on December 5, 2018 at 1:50 pm
Quantitative image analyses, such as computer-aided diagnosis (CAD) algorithms, are continually being developed to help radiologists more objectively and clearly interpret mammograms. Radiomics, an ex... […]
- Former 'Top Model' contestant Jael Strauss dies 2 months after breast cancer diagnosis on December 4, 2018 at 11:11 pm
Jael Strauss, a former contestant on "America's Next Top Model," died Tuesday morning, two months after announcing she was diagnosed with inflammatory breast cancer, TMZ reports. She was 34. Strauss c... […]
- ANTM Alum Jael Strauss Dies at Age 34 — 2 Months After Being Diagnosed with Breast Cancer on December 4, 2018 at 6:40 pm
Strauss died in hospice on Tuesday morning, according to TMZ, and was unconscious for a few days. “The one blessing was that we were able to show her how loved she was before she passed,” her family s... […]
- Former ‘America’s Next Top Model’ Contestant Jael Strauss Has Died Of Breast Cancer on December 4, 2018 at 5:04 pm
Jael revealed in October that she was diagnosed with "incurable" stage IV inflammatory breast cancer. Inflammatory breast cancer is a very rare, rapidly progressing type of breast cancer. Jael Strauss ... […]
- Jael Strauss dead: America's Next Top Model star dies at 34, months after cancer diagnosis on December 4, 2018 at 4:00 pm
Jael Strauss has passed away at the age of 34 after she was diagnosed with stage IV breast cancer on October 2. The former America's Next Top Model contestant died on December 4 at 11am from incurable ... […]
via Bing News